Phase 3 study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer: BROCADE3 - Diéras, V; Han, H S; Kaufman, B (Ann Oncol, 2019)
. doi:810.1093/annonc/mdz1394